The RxView Blog

Real world data, analytics, and insights for healthcare decision makers

Advera Health Analytics, Inc.

Connect with Advera Health at the AMCP 2016 Annual Meeting

Posted by Brian Overstreet on April 19, 2016

In last week's post we wrote about the need for both managed care and pharmaceutical manufacturers to engage in conversation around ways to make pre-approval drug evidence more readily available, and more importantly, actionable. The AMCP Managed Care & Specialty Pharmacy Annual Meeting, taking place at the Moscone West in San Francisco this week is the perfect opportunity to make this happen. 

Read More

Topics: Evidence, AMCP

Watson Health is the Ultimate Data Parasite

Posted by Jim Davis on March 3, 2016

One year after its birth, the ultimate data parasite has come of age by latching on to a $3 billion host. It is big, blue, pretty good at Jeopardy, and if you were to believe the data detractors, utterly useless.

Read More

Topics: Big Data, FAERS, Evidence

A Quest for Evidence

Posted by Brian Overstreet on February 12, 2016

This week marks the sixth anniversary of the date that Bob Kyle, Henry Duong, and I incorporated Advera Health Analytics.  We started this journey with a mission to improve patient outcomes by making drug safety data more accessible and actionable.  We spent the early years developing our technologies, building our data delivery platform, and subjecting our early methodologies to peer review.  Two years ago we began to commercialize our enterprise data product and since then we’ve grown exponentially.

Read More

Topics: Clinical Trials, Hepatitis C, Clinical Evidence, Real World Evidence, Evidence

Subscribe to Email Updates